股票代码：300381 股票简称：溢多利 公告编号：2025-052 广东溢多利生物科技股份有限公司 关于控股股东部分股份质押及解除质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 广东溢多利生物科技股份有限公司（以下简称"公司"）于 2025 年 12 月 1 日接到控股股东珠海市金大地投资有限公司（以下简称"金大地投资"）的 通知，金大地投资将其所持有的本公司部分股份办理了质押及解除质押手续， 具体事项如下： 一、股东股份质押、解除质押的基本情况 | 股东 | 是否为 第一大 股东及 | 本次质押 数量 | 占其所 持股份 | 占公司总 股本比例 | 是否为 | 是否为补 | 质押 | 质押 | 质权人 | 质押 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 名称 | 一致行 | （万股） | 比例 | （%） | 限售股 | 充质押 | 起始日 | 到期日 | | 用途 | | | | | （%） | | | | | | | | | | 动人 | ...

Core Insights - The modern livestock industry is increasingly demanding diverse animal nutrition, leading to higher requirements for feed performance, which traditional standardized products can no longer meet [1] - Additive premix feed fills the market gap with flexible formulation design and precise nutritional supply, improving feed utilization, reducing farming costs, and enhancing animal growth performance and product quality [1] Industry Overview - Additive premix feed consists of two or more nutritional feed additives mixed with carriers or diluents, including compound premix feed, trace element premix feed, and vitamin premix feed [3] - The production of additive premix feed in China has experienced fluctuations, with production reaching 542.6 million tons in 2019, a decrease of 16.9% year-on-year, and recovering to 594.5 million tons in 2020, a growth of 9.6% [1][8] - In 2021, production increased to 663.1 million tons, a year-on-year growth of 11.54%, but fell to 652.2 million tons in 2022 due to various factors, including the pandemic [1][8] - In 2023, production rebounded to 709.1 million tons, an increase of 8.7% year-on-year, but is expected to decline to 695.1 million tons in 2024 due to adjustments in pig production capacity and reduced livestock inventory [1][8] Industry Policies - The industry has seen a series of supportive and regulatory policies aimed at promoting standardization and efficiency, such as the 2024 "Green Sword Protect Grain Safety" enforcement action focusing on illegal production and sales of feed additives [4][6] - The 2025 Feed Quality Safety Supervision Work Plan emphasizes the inspection of banned substances and illegal additives in various feed products, including premix feeds [4][6] Industry Chain - The upstream of the additive premix feed industry includes feed raw materials like soybeans, corn, and fish meal, while the midstream involves the production of various types of premix feeds [6] - The downstream application includes livestock farming sectors such as pig, poultry, and aquaculture [6] Market Dynamics - The additive premix feed market is characterized by a clear competitive structure, with leading companies like New Hope, Tongwei, and Da Bei Nong forming the first tier, while other companies like Haida Group and Zhengbang Technology represent the second tier [10][12] - The market is expected to consolidate further, with smaller companies facing challenges due to limited innovation and sales channels [10][12] Future Trends - The industry is moving towards precise product functionality and value enhancement, focusing on tailored formulations for different livestock species and growth stages [16] - Technological advancements will drive the integration of biotechnology and smart manufacturing, optimizing formulation structures and improving production processes [17] - A comprehensive service model will emerge, extending beyond product provision to include technical support and real-time monitoring for farmers [18]

Core Points - The company Yiduoli (300381) reported that as of November 20, 2025, the number of shareholders is 20,331 [1] Summary by Category - **Company Information** - Yiduoli has a total of 20,331 shareholders as of the specified date [1]

Core Viewpoint - The company, Yiduoli (300381.SZ), is actively engaged in the development and production of aquaculture feed additives, including enzyme preparations and plant extracts, and has established a collaboration with the Chinese Academy of Agricultural Sciences to enhance the gut health of aquatic animals [1][3]. Group 1 - The company currently offers products such as aquaculture enzyme preparations, plant extracts, and other feed additives [1]. - The collaboration with the Chinese Academy of Agricultural Sciences has resulted in significant advancements in improving the gut health of aquatic animals [1]. - The company plans to continue its business in aquaculture enzyme preparations and other related feed additives [1].

Core Viewpoint - The company, Yiduoli (300381.SZ), is actively engaged in the production of aquaculture enzyme preparations, plant extracts, and other feed additives, emphasizing its collaboration with the Chinese Academy of Agricultural Sciences to enhance the gut health of aquatic animals [1] Group 1 - The company offers a range of products including aquaculture enzyme preparations and plant extracts [1] - Collaboration with the Chinese Academy of Agricultural Sciences has resulted in successful product implementation [1] - The company aims to continue its focus on aquaculture enzyme preparations and other feed additive businesses [1]

Core Insights - The phytic acid enzyme market is experiencing significant growth, primarily driven by increased demand in the feed industry, especially after the ban on antibiotics in animal feed in China in 2020, positioning phytic acid enzymes as ideal alternatives [1][7] - China's annual production of phytic acid enzymes has significantly increased, from 43,200 tons in 2015 to an expected 120,600 tons by 2024, indicating a robust growth trajectory [1][8] - The global phytic acid enzyme market is projected to grow from $513 million in 2023 to $822 million by 2029, with a compound annual growth rate (CAGR) of 8.2% [6] Industry Overview - Phytic acid enzymes belong to the class of phosphoric monoester hydrolases and are crucial for enhancing the bioavailability of minerals in plant-based feeds by breaking down phytic acid [2] - The industry has evolved through three stages: initial development in the 1990s, rapid growth from 2001 to 2012, and a mature phase from 2013 onwards, with domestic products replacing imports and achieving international technical standards [3][4] Industry Chain - The upstream of the phytic acid enzyme industry includes raw materials such as wheat, barley, and microorganisms, while the downstream applications span food, pharmaceutical, and feed industries [5] - The feed industry is the largest application area for phytic acid enzymes, driven by the need to improve feed efficiency and reduce costs, with a notable increase in China's feed production reaching 250.7 million tons in the first nine months of 2025, up 6.4% year-on-year [5][6] Competitive Landscape - The global phytic acid enzyme market is highly competitive, with companies like Novozymes, DuPont, and DSM holding significant market shares due to their technological advantages and patent protections [8] - Chinese companies such as Blue Horizon Biotechnology, Yidali, and Xinghuo Technology are emerging as strong competitors, gradually capturing high-end market segments [8] Development Trends - Technological innovation is a key driver for the industry, with advancements in enzyme production and purification methods expected to enhance yield and efficiency [10] - The application of phytic acid enzymes is expanding beyond traditional uses in poultry and pig feed to include aquaculture and organic agriculture, indicating new growth opportunities [11] - Environmental sustainability is becoming increasingly important, with stricter regulations prompting phytic acid enzyme companies to enhance their eco-friendly practices and production processes [12]

Core Points - The Shanghai Composite Index is at 4017.68 points, above the six-month moving average, with a slight decline of 0.29% [1] - A total trading volume of A-shares reached 15648.48 billion yuan today [1] - 113 A-shares have surpassed the six-month moving average, with notable stocks showing significant deviation rates [1] Summary by Category Stock Performance - The top three stocks with the highest deviation rates from the six-month moving average are: - Electric Investment and Financing (9.07%) - Jie Rong Technology (7.54%) - Annie Shares (4.91%) [1] - Other stocks with smaller deviation rates that have just crossed the six-month line include: - Baoland, Zhongnong Lihua, and Subote [1] Trading Data - The trading performance of selected stocks includes: - Electric Investment and Financing: +9.94% with a turnover rate of 2.09% - Jie Rong Technology: +10.00% with a turnover rate of 8.20% - Annie Shares: +6.44% with a turnover rate of 18.47% [1] - Additional stocks with notable performance include: - Yahua Electronics: +6.29% - Zhonglu Shares: +7.08% - Jinlihua Electric: +4.81% [1]

Core Viewpoint - Yidoli is a leading domestic producer of biological enzyme preparations and steroid hormone raw materials, with strong R&D capabilities and a complete industry chain advantage [1] Group 1: Business Overview - Yidoli was established on September 3, 1991, and listed on the Shenzhen Stock Exchange on January 28, 2014, with its registered and office address in Zhuhai, Guangdong Province [1] - The main business includes R&D, production, sales, and services of biological enzyme preparations, steroid hormone raw materials, plant extracts, and animal nutrition and health products, providing comprehensive biotechnology solutions [1] Group 2: Financial Performance - For Q3 2025, Yidoli's operating revenue was 613 million yuan, ranking 27th out of 47 in the industry, significantly lower than the industry leader, Pro Pharmaceutical, which had 7.764 billion yuan, and the second place, Nentek Technology, with 7.13 billion yuan [2] - The net profit for the same period was 19.49 million yuan, ranking 34th in the industry, with a notable gap compared to the industry leader, Zhejiang Pharmaceutical, at 867 million yuan, and Pro Pharmaceutical at 700 million yuan [2] Group 3: Financial Ratios - As of Q3 2025, Yidoli's debt-to-asset ratio was 8.95%, down from 9.68% year-on-year, significantly lower than the industry average of 27.75%, indicating strong solvency [3] - The gross profit margin for the same period was 46.51%, slightly up from 46.43% year-on-year, and higher than the industry average of 35.38%, reflecting strong profitability [3] Group 4: Executive Compensation - Chairman Chen Shaomei's salary for 2024 was 1.1986 million yuan, an increase of 1,900 yuan from 2023 [4] - President Zhou Derong's salary for 2024 was 924,800 yuan, an increase of 2,100 yuan from 2023 [4] Group 5: Shareholder Information - As of September 30, 2025, the number of A-share shareholders was 20,100, with an average holding of 24,400 circulating A-shares, showing no change from the previous period [5] - Among the top ten circulating shareholders, the Guotai Zhongzheng Livestock Breeding ETF ranked as the fourth largest, holding 8.6164 million shares, an increase of 3.0406 million shares from the previous period [5]

Core Insights - Yiduoli (300381.SZ) reported its Q3 2025 results, highlighting a significant increase in institutional investor holdings, which now account for 31.44% of the total shares outstanding [1] Institutional Holdings - As of October 28, 2025, three institutional investors disclosed their holdings in Yiduoli A-shares, totaling 154 million shares [1] - The institutional investors include Zhuhai Jindadi Investment Co., Ltd., Zheshang Bank Co., Ltd. - Guotai Zhongzheng Livestock Breeding ETF, and Zhuhai Juyi Fund Management Co., Ltd. - Juyi Yuer No. 2 Private Securities Investment Fund [1] - The overall institutional holding percentage increased by 0.85 percentage points compared to the previous quarter [1] Public Fund Holdings - One public fund, Guotai Zhongzheng Livestock Breeding ETF, increased its holdings during this period, with an increase percentage of 0.62% [1] - Twelve public funds that were not disclosed in the previous quarter include notable names such as China Merchants Zhongzheng Livestock Breeding ETF and Ping An Zhongzheng Livestock Breeding ETF [1]

Core Insights - The company reported a revenue of 613 million yuan for the first three quarters of 2025, representing a year-on-year growth of 0.77% [1] - The net profit attributable to shareholders decreased by 57.47% to 18.2044 million yuan [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses increased by 33.65% to 18.7673 million yuan [1] - The basic earnings per share were 0.0371 yuan [1]